J Cerebrovasc Endovasc Neurosurg.  2016 Mar;18(1):12-18. 10.7461/jcen.2016.18.1.12.

Preoperative Embolization of Extra-axial Hypervascular Tumors with Onyx

Affiliations
  • 1Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • 2Division of Neurosurgery, Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
  • 3Department of Neurosurgery, Barrow Neurological Institute, Phoenix, AZ, USA. Bgross83@gmail.com

Abstract


OBJECTIVE
Preoperative endovascular embolization of intracranial tumors is performed to mitigate anticipated intraoperative blood loss. Although the usage of a wide array of embolic agents, particularly polyvinyl alcohol (PVA), has been described for a variety of tumors, literature detailing the efficacy, safety and complication rates for the usage of Onyx is relatively sparse.
MATERIALS AND METHODS
We reviewed our single institutional experience with pre-surgical Onyx embolization of extra-axial tumors to evaluate its efficacy and safety and highlight nuances of individualized cases.
RESULTS
Five patients underwent pre-surgical Onyx embolization of large or giant extra-axial tumors within 24 hours of surgical resection. Four patients harbored falcine or convexity meningiomas (grade I in 2 patients, grade II in 1 patient and grade III in one patient), and one patient had a grade II hemangiopericytoma. Embolization proceeded uneventfully in all cases and there were no complications.
CONCLUSION
This series augments the expanding literature confirming the safety and efficacy of Onyx in the preoperative embolization of extra-axial tumors, underscoring its advantage of being able to attain extensive devascularization via only one supplying pedicle.

Keyword

Embolization; Endovascular; Meningioma; Onyx; Tumor
Full Text Links
  • JCEN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr